| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 101.061 | 121.049 | 176.124 | 157.513 | 428.929 | 596.691 | 792.317 | 752.029 | 928.900 | 1.345.599 |
| Total Income - EUR | 101.121 | 121.253 | 176.207 | 157.560 | 438.248 | 599.708 | 801.613 | 756.632 | 929.746 | 1.350.081 |
| Total Expenses - EUR | 86.162 | 104.500 | 144.355 | 132.945 | 342.649 | 483.403 | 574.995 | 477.833 | 805.611 | 1.144.609 |
| Gross Profit/Loss - EUR | 14.959 | 16.753 | 31.852 | 24.615 | 95.599 | 116.305 | 226.618 | 278.799 | 124.134 | 205.472 |
| Net Profit/Loss - EUR | 12.773 | 15.350 | 29.948 | 23.039 | 91.304 | 110.749 | 218.763 | 271.881 | 116.481 | 186.232 |
| Employees | 2 | 2 | 6 | 5 | 5 | 5 | 6 | 6 | 7 | 9 |
Check the financial reports for the company - Gyniclinique Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.882 | 25.930 | 18.844 | 111.515 | 174.293 | 200.460 | 296.087 | 247.061 | 403.679 | 379.375 |
| Current Assets | 11.573 | 518 | 27.951 | 8.519 | 30.524 | 98.683 | 138.484 | 198.960 | 63.997 | 125.694 |
| Inventories | 108 | 0 | 0 | 900 | 1.150 | 2.115 | 0 | 0 | 0 | 1.516 |
| Receivables | 5.056 | 202 | 3.887 | 1.002 | 2.545 | 2.062 | 59.494 | 172.899 | 83.817 | 74.912 |
| Cash | 6.409 | 315 | 24.064 | 6.617 | 26.829 | 94.507 | 78.990 | 26.061 | -19.819 | 49.266 |
| Shareholders Funds | 15.746 | 10.387 | 30.053 | 52.541 | 142.828 | 212.069 | 235.831 | 271.978 | 145.783 | 321.367 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 14.737 | 16.250 | 16.769 | 67.617 | 62.100 | 87.181 | 198.892 | 174.265 | 324.040 | 184.432 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gyniclinique Srl